The estimated Net Worth of Paul Kim is at least $23.8 Milion dollars as of 3 September 2024. Mr. Kim owns over 1,674 units of Fulgent Genetics Inc stock worth over $4,556,212 and over the last 8 years he sold FLGT stock worth over $18,392,510. In addition, he makes $823,481 as Chief Financial Officer at Fulgent Genetics Inc.
Paul has made over 41 trades of the Fulgent Genetics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 1,674 units of FLGT stock worth $36,761 on 3 September 2024.
The largest trade he's ever made was selling 136,643 units of Fulgent Genetics Inc stock on 17 August 2020 worth over $5,755,403. On average, Paul trades about 4,997 units every 32 days since 2016. As of 3 September 2024 he still owns at least 209,481 units of Fulgent Genetics Inc stock.
You can see the complete history of Mr. Kim stock trades at the bottom of the page.
Paul Kim CPA serves as Chief Financial Officer of the Company. Mr. Kim was retired from 2011 until 2015 and served as Chief Financial Officer of Cogent, Inc., a biometric identification services and products company, from January 2004 until 2011. Mr. Kim’s past experience also includes service as the Chief Financial Officer of JNI Corporation, a publicly traded storage area network technology company, from September 2002 until December 2003, as Vice President, Finance and Corporate Controller at JNI from October 1999 to August 2002 and as Vice President of Finance and Administration for Datafusion Inc., a privately held software development company, from January 1998 until October 1999. From April 1996 to January 1998, Mr. Kim was the Corporate Controller for Interlink Computer Sciences, Inc., a publicly-traded enterprise software company. From January 1990 to April 1996, Mr. Kim worked for Coopers and Lybrand L.L.P., leaving as an audit manager. Mr. Kim received a B.A. in Economics from the University of California at Berkeley in 1989 and is a Certified Public Accountant.
As the Chief Financial Officer of Fulgent Genetics Inc, the total compensation of Paul Kim at Fulgent Genetics Inc is $823,481. There are no executives at Fulgent Genetics Inc getting paid more.
Paul Kim is 52, he's been the Chief Financial Officer of Fulgent Genetics Inc since 2016. There are 10 older and no younger executives at Fulgent Genetics Inc. The oldest executive at Fulgent Genetics Inc is John Bolger, 73, who is the Independent Director.
Paul's mailing address filed with the SEC is 4978 Santa Anita Ave Suite 205, Temple City, CA 91780, USA.
Over the last 9 years, insiders at Fulgent Genetics Inc have traded over $32,817,108 worth of Fulgent Genetics Inc stock and bought 1,136,382 units worth $9,558,758 . The most active insiders traders include Hanlin Gao, Ming Hsieh a Paul Kim. On average, Fulgent Genetics Inc executives and independent directors trade stock every 28 days with the average trade being worth of $848,250. The most recent stock trade was executed by Paul Kim on 3 September 2024, trading 1,674 units of FLGT stock currently worth $36,761.
mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques
Fulgent Genetics Inc executives and other stock owners filed with the SEC include: